Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Nov 1;89(21):10016-20.
doi: 10.1073/pnas.89.21.10016.

Complement activation by beta-amyloid in Alzheimer disease

J Rogers  1 , N R Cooper, S Webster, J Schultz, P L McGeer, S D Styren, W H Civin, L Brachova, B Bradt, P Ward, et al.
Affiliations

Complement activation by beta-amyloid in Alzheimer disease

J Rogers et al. Proc Natl Acad Sci U S A. .

Abstract

Alzheimer disease (AD) is characterized by excessive deposition of the beta-amyloid peptide (beta-AP) in the central nervous system. Although several lines of evidence suggest that beta-AP is neurotoxic, a mechanism for beta-AP toxicity in AD brain remains unclear. In this paper we provide both direct in vitro evidence that beta-AP can bind and activate the classical complement cytolytic pathway in the absence of antibody and indirect in situ evidence that such actions occur in the AD brain in association with areas of AD pathology.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Brain Res Mol Brain Res. 1992 Jun;14(1-2):109-16 - PubMed
    1. Acta Neuropathol. 1982;57(2-3):239-42 - PubMed
    1. J Neuroimmunol. 1991 Apr;32(1):19-28 - PubMed
    1. Neurosci Lett. 1990 Oct 30;119(1):75-8 - PubMed
    1. Lab Invest. 1991 Mar;64(3):345-51 - PubMed

Publication types